Omega Therapeutics, Inc. (OMGA) Misses Q1 EPS by 3c

Omega Therapeutics, Inc. (NASDAQ: OMGA) reported Q1 EPS of ($0.36), $0.03 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $2.36 million versus the consensus estimate of $1.17 million.

For earnings history and earnings-related data on Omega Therapeutics, Inc. (OMGA) click here.

You May Also Be Interested In

• Is the global equity rally broadening? UBS weighs in
• ICICI Securities Resumes Dalmia Bharat Ltd (DALBHARA:IN) at Add (2)
• Morgan Stanley Starts Tier IV Inc (593A:JP) at Overweight